← Leaderboards
Joseph Wang Franses
Massachusetts General Hospital
$1,067,879
Attributed
$1,067,879
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $271.9K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,067,879 · 1
By mechanism
K08$1,067,879 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- E. Antonio Chiocca$34,514,665
- Frederick M Ausubel$22,351,893
- Kazuhide Hayakawa$6,403,808
- Alexei A Bogdanov$13,760,247
- David Tsai Ting$4,336,400
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectClinical PracticeAngiogenic FactorAnimal ExperimentsAdvisory CommitteesAgarAutomobile DrivingBehaviorBiological MarkersBiological ModelsBiologyAnimal ModelBlood VesselsCancer CellCancer CenterCancer GenomicsCareerCareer DevelopmentCell CommunicationCell DensityCell LineCell ModelCellsCoculture Techniques
Grant awards (4)
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma$265,315
K08 · FY2025 · CA · contact PI
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma$265,315
K08 · FY2024 · CA · contact PI
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma$265,315
K08 · FY2023 · CA · contact PI
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma$271,934
K08 · FY2022 · CA · contact PI